tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

NGNE Stock Latest News

Neurogene Highlights Progress in Rett Syndrome Program
Company AnnouncementsNeurogene Highlights Progress in Rett Syndrome Program
5d ago
8K
NGNE
Neurogene files to sell 4M shares of common stock for holders
PremiumThe Fly
Neurogene files to sell 4M shares of common stock for holders
2M ago
NGNE
3 Stocks to Buy Now, 12/2/2024, According to Corporate Insiders
PremiumMarket News
3 Stocks to Buy Now, 12/2/2024, According to Corporate Insiders
2M ago
META
NGNE
Neurogene Adjusts Clinical Trial After Setback
PremiumCompany Announcements
Neurogene Adjusts Clinical Trial After Setback
2M ago
8K
NGNE
Neurogene price target lowered to $45 from $60 at BMO Capital
PremiumThe Fly
Neurogene price target lowered to $45 from $60 at BMO Capital
2M ago
NGNE
Neurogene Inc. Faces Uncertainty with NGN-101 Program Amid FDA Challenges and Strategic Hurdles
PremiumCompany AnnouncementsNeurogene Inc. Faces Uncertainty with NGN-101 Program Amid FDA Challenges and Strategic Hurdles
2M ago
NGNE
Neurogene price target lowered to $45 from $60 at BMO Capital
Premium
The Fly
Neurogene price target lowered to $45 from $60 at BMO Capital
2M ago
NGNE
Neurogene price target lowered to $46 from $72 at Baird
Premium
The Fly
Neurogene price target lowered to $46 from $72 at Baird
2M ago
NGNE
Neurogene selloff on safety event an overreaction, says H.C. Wainwright
PremiumThe Fly
Neurogene selloff on safety event an overreaction, says H.C. Wainwright
2M ago
NGNE
Closing Bell Movers: Super Micro up 28% on compliance update
PremiumThe Fly
Closing Bell Movers: Super Micro up 28% on compliance update
2M ago
ACM
SYM
Neurogene reports Q3 EPS ($1.19), consensus ($1.22)
PremiumThe Fly
Neurogene reports Q3 EPS ($1.19), consensus ($1.22)
2M ago
NGNE
Neurogene Adjusts NGN-401 Trial After Adverse Event
PremiumCompany Announcements
Neurogene Adjusts NGN-401 Trial After Adverse Event
2M ago
8K
NGNE
Neurogene provides update on NGN-401 clinical trial for Rett syndrome
PremiumThe FlyNeurogene provides update on NGN-401 clinical trial for Rett syndrome
2M ago
NGNE
Neurogene provides update on NGN-401 clinical trial for Rett syndrome
Premium
The Fly
Neurogene provides update on NGN-401 clinical trial for Rett syndrome
2M ago
NGNE
Neurogene Reports Promising Interim Results for NGN-401 Trial
Premium
Company Announcements
Neurogene Reports Promising Interim Results for NGN-401 Trial
2M ago
8K
NGNE
Neurogene price target raised to $60 from $44 at Stifel
PremiumThe Fly
Neurogene price target raised to $60 from $44 at Stifel
2M ago
NGNE
Neurogene price target lowered to $60 from $65 at BMO Capital
PremiumThe Fly
Neurogene price target lowered to $60 from $65 at BMO Capital
2M ago
NGNE
Neurogene price target raised to $72 from $54 at Baird
PremiumThe Fly
Neurogene price target raised to $72 from $54 at Baird
2M ago
NGNE
Neurogene price target raised to $55 from $49 at H.C. Wainwright
PremiumThe Fly
Neurogene price target raised to $55 from $49 at H.C. Wainwright
2M ago
NGNE
Closing Bell Movers: Live Nation jumps 6% after Q3 earnings beat
PremiumThe FlyClosing Bell Movers: Live Nation jumps 6% after Q3 earnings beat
2M ago
AVD
IAC
Neurogene reports ‘positive’ interim efficacy data from NGN-401 participants
Premium
The Fly
Neurogene reports ‘positive’ interim efficacy data from NGN-401 participants
2M ago
NGNE
Neurogene Secures $200M for Genetic Therapy Development
Premium
Company Announcements
Neurogene Secures $200M for Genetic Therapy Development
2M ago
8K
NGNE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >